Vol 64, No 1 (2014)

Date published: 2014-03-04

Table of Contents

open access

Original article

Cabazitaxel shows a consistently greater survival benefit compared to mitoxantrone in patients with mCRPC

Johann S. de Bono, Oliver Sartor, Christine Geffriaud-Ricouard, Florence Joulain, Anders Widmark

Research paper (original)

DOI: 10.5603/NJO.2014.0001
Nowotwory. Journal of Oncology 2014;64(1):1-6.

Chemopreventive activity of fluphenazine and its analogues in human lymphocyte cultures preincubated with ceramide synthase inhibitor

Agata Jaszczyszyn, Kazimierz Gąsiorowski, Piotr Świątek, Wiesław Malinka, Urszula Kaziród

Research paper (original)

DOI: 10.5603/NJO.2014.0002
Nowotwory. Journal of Oncology 2014;64(1):7-15.

Stereotactic hypofractionated radiotherapy for prostate cancer patients — a preliminary report

Monika Rucińska, Marta Stefańczyk, Bartosz Kowalczuk, Joanna Minczewska, Sergiusz Nawrocki

Research paper (original)

DOI: 10.5603/NJO.2014.0003
Nowotwory. Journal of Oncology 2014;64(1):16-23.

Effectiveness and costs of breast cancer therapy in Poland: a regional approach

Adam Kozierkiewicz, Roman Topór-Mądry, Andrzej Śliwczyński, Marcin Pakulski, Jacek Jassem

Research paper (original)

DOI: 10.5603/NJO.2014.0004
Nowotwory. Journal of Oncology 2014;64(1):24-32.

Breast cancer treatment outcomes, therapy options and costs in Poland (2005–2007)

Krzysztof Herman, Andrzej Śliwczyński, Wojciech M. Wysocki

Research paper (original)

DOI: 10.5603/NJO.2014.0005
Nowotwory. Journal of Oncology 2014;64(1):33-39.
Review article

Review of preoperative hormonal therapy in patients with breast cancer

Sylwia Dębska-Szmich, Magdalena Krakowska, Urszula Czernek, Maja Habib-Lisik, Agnieszka Zięba, Piotr Potemski

Review paper

DOI: 10.5603/NJO.2014.0006
Nowotwory. Journal of Oncology 2014;64(1):40-47.

MicroRNA molecules as a significant constituent in gene regulation mechanisms related to cancer

Michał Budzyński, Anna Grenda, Agata A. Filip

Review paper

DOI: 10.5603/NJO.2014.0007
Nowotwory. Journal of Oncology 2014;64(1):48-60.

The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations

Jacek Jassem, Wojciech Biernat, Maciej Bryl, Joanna Chorostowska-Wynimko, Rafał Dziadziuszko, Paweł Krawczyk, Radzisław Kordek, Dariusz M. Kowalski, Maciej Krzakowski, Włodzimierz Olszewski, Tadeusz Orłowski, Rodryg Ramlau, Witold Rzyman

Guidelines / Expert consensus

DOI: 10.5603/NJO.2014.0008
Nowotwory. Journal of Oncology 2014;64(1):61-75.
Oncological debates

Should we use radiotherapy in DLBCL? Vote for YES

Renata Zaucha

DOI: 10.5603/NJO.2014.0009
Nowotwory. Journal of Oncology 2014;64(1):76-80.

Should radiotherapy be used in diffuse large B-cell lymphoma? Vote for NO

Jan Walewski

DOI: 10.5603/NJO.2014.0010
Nowotwory. Journal of Oncology 2014;64(1):81-83.

Should preoperative radiotherapy be standard procedure for locally advanced rectal cancer? YES

Krzysztof Bujko

DOI: 10.5603/NJO.2014.0011
Nowotwory. Journal of Oncology 2014;64(1):84-89.

Should preoperative radiotherapy be standard procedure for locally advanced rectal cancer? NO

Adam Dziki, Łukasz Dziki

DOI: 10.5603/NJO.2014.0012
Nowotwory. Journal of Oncology 2014;64(1):90-91.

Spotkanie po ASCO 2013

Barbara Radecka

Conference report / Report

DOI: 10.5603/NJO.2014.0013
Nowotwory. Journal of Oncology 2014;64(1):92-100.
Current events in Polish oncology

90-lecie powstania Komitet Daru Narodowego dla Marii Skłodowskiej-Curie

Other materials agreed with the Editors

DOI: 10.5603/NJO.2014.0014
Nowotwory. Journal of Oncology 2014;64(1):101-103.
Journal Club

Journal Club

NOWOTWORY Journal of Oncology

Other materials agreed with the Editors

DOI: 10.5603/NJO.2014.0015
Nowotwory. Journal of Oncology 2014;64(1):104-108.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl